NextEra Energy, Inc. vs uniQure N.V. Ordinary Shares — how do they compare? NextEra Energy, Inc. trades at $78.72 (market cap $163.17B), while uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.48B). The key difference: NextEra Energy, Inc. is far larger — about 110.3× uniQure N.V. Ordinary Shares's market cap, and NextEra Energy, Inc. pays a 3.19% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold NextEra Energy, Inc. for 83 Days and uniQure N.V. Ordinary Shares for 0 Days on average.
| NEE | QURE | |
|---|---|---|
Market Cap | $163.17B | $1.48B |
Volume | 9,492,162 | 2,488,780 |
Sector | Utilities | Health |
52-Week High | $97.88 | $70.59 |
52-Week Low | $75.49 | $9.03 |
Typical Hold Time | 83 Days | 0 Days |
Enterprise Value | $270.50B | $728.62M |
Dividend Yield | 3.19% | — |
Signals from Pluang's Aura AI — not financial advice
NextEra Energy (NEE) trades at $78.37, down 0.18% today, with a bullish technical signal but mixed indicators. The company reported strong earnings beats in Q1 and Q2 2026, with revenue growth and a net income margin of 32.4%. Recent news highlights expansion in gas generation and a major infrastructure partnership. Analyst consensus is strongly bullish with a $96 price target, though the stock is near a 52-week low of $74.78, indicating potential value.
Outlook is positive due to robust fundamentals and growth initiatives, but risks include rising debt levels and interest rate sensitivity. The stock offers a dividend yield with upcoming payment, supporting income investors. Upside potential exists if earnings momentum continues, but macroeconomic headwinds and competitive pressures warrant caution.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
NextEra Energy's regulated utility, Florida Power & Light, distributes power to more than 5 million customers in Florida. FP&L contributes more than 60% of the group's operating earnings. The renewable energy segment generates and sells power throughout the United States and Canada. Consolidated generation capacity totals more than 50 gigawatts and includes natural gas, nuclear, wind, and solar assets.
Read more on NEE →uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →